CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients

European Journal of Immunology

Volumn 29, Issue 6, 1999, Pages 1990-1999

  Speiser, Daniel E ^a   Valmori, Danila ^a   Rimoldi, Donata ^a   Pittet, Mikaël J ^a   Liénard, Danielle ^a,b   Cerundolo, Vincenzo ^c   MacDonald, H Robson ^a   Cerottini, Jean Charles ^a   Romero, Pedro ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cytotoxic T lymphocyte; Killer inhibitory receptor; Melanoma; NK receptor

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN CELL; MELANOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0032990260     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199906)29:06<1990::AID-IMMU1990>3.0.CO;2-9     Document Type: Article

References (45)

1. Jorgensen, J. L., Reay, P. A., Ehrich, E. W. and Davis, M. M., Molecular components of T-cell recognition. Annu. Rev. Immunol. 1992. 10: 835-873.
2. Toyonaga, B. and Mak, T. W., Genes of the T-cell antigen receptor in normal and malignant T cells. Annu. Rev. Immunol. 1987. 5: 585-620.
3. Schwartz, R. H., Costimulation of T lymphocytes: The role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992. 71: 1065-1068.
4. Linsley, P. and Ledbetter, J. A., The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 1993. 11: 191-212.
5. Lenschow, D. J., Walunas, T. L. and Bluestone, J. A., CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 1996. 14: 233-258.
6. Litwin, V., Gumperz, J., Parham, P., Phillips, J. H. and Lanier, L. L., Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J. Exp. Med. 1993. 178: 1321-1336.
7. Ciccone, E., Pende, D., Viale, O., Di Donato, C., Tripodi, G., Orengo, A. M., Guardiola, J., Moretta, A. and Moretta, L., Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans. J. Exp. Med. 1992. 175: 709-718.
8. Gumperz, J., Litwin, V., Phillips, J. H., Lanier, L. L. and Parham, P., The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 1995. 181: 1133-1144.
9. Moretta, A., Vitale, M., Sivori, S., Bottino, C., Morelli, L., Augugliaro, R., Bararesi, M., Pende, D., Ciccone, E., Lopez-Botet, M. and Moretta, L., Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J. Exp. Med. 1994. 180: 545-555.
10. Ferrini, S., Cambiaggi, A., Meazza, R., Sforzini, S., Marciano, S., Mingari, M. C. and Moretta, L., T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 1994. 24: 2294-2298.
11. Phillips, J. H., Gumperz, J. E., Parham, P. and Lanier, L. L., Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995. 268: 403-405.
12. Ikeda, H., Lethe, B., Lehmann, F., Van Baren, F., Baurain, J.-F., De Smet, Ch., Chambost, H., Vitale, M., Moretta, A., Boon, T. and Coulie, P. G., Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 1997. 6: 199-208.
13. Bakker, A. B. H., Phillips, J. H., Figdor, C. G. and Lanier, L. L., Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta cells, and antigen-specific CTL. J. Immunol. 1998. 160: 5239-5245.
14. Noppen, C., Schaefer, C., Zajac, P., Schütz, A., Kocher, T., Kloth, J., Heberer, M., Colonna, M., De Libero, G. and Spagnoli, G. C., C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity. Eur. J. Immunol. 1998. 28: 1134-1142.
15. Azuma, M., Phillips, J. H. and Lanier, L. L., CD28-T lymphocytes. Antigenic and functional properties. J. Immunol. 1993. 150: 1147-1159.
16. - T cell expansion - anergy or activation? Clin. Exp. Immunol. 1996. 104: 180-184.
17. + T cells. J. Exp. Med. 1997. 186: 1407-1418.
18. - T cells. J. Immunol. 1993. 151: 2237-2246.
19. high T cell population. Eur. J. Immunol. 1993. 23: 1057-1063.
20. - T cells in healthy ageing people, including centenarians. Immunol. Today 1996. 11: 203-205.
21. Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis, U. J., Angman, L., Cella, M. and Lopez-Botet, M., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997. 186: 1809-1818.
22. Romero, P., Dunbar, P. R., Valmori, D., Pittet, M., Ogg, G. S., Rimoldi, D., Chen, J. L., Liénard, D., Cerottini, J.-C. and Cerundolo, V., Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytotoxic T lymphocytes. J. Exp. Med. 1998. 188: 1641-1650.
23. Posnett, D. N., Sinha, R., Kabak, S. and Russo, C., Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". J. Exp. Med. 1994. 179: 609-618.
24. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 1996. 93: 12433-12438.
25. + counterparts. J. Immunol. 1996. 156: 3587-3594.
26. + T cells. Proc. Natl. Acad. Sci. USA 1998. 95: 1172-1177.
27. Lopez-Botet, M., Moretta, L. and Strominger, J. L., NK-cell receptors and recognition of MHC class I molecules. Immunol. Today 1996. 17: 212-214.
28. Hintzen, R. Q., de Jong, R., Lens, S. M., Brouwer, M., Baars, P. and van Lier, R. A., Regulation of CD27 expression on subsets of mature T-lymphocytes. J. Immunol. 1993. 151: 2426-2435.
29. + T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients. Eur. J. Immunol. 1994. 24: 2882-2888.
30. + T cells: effector T cells. Int. Immunol. 1998. 10: 1837-1845.
31. - T cells. AIDS 1994. 8: 431-441.
32. + cells in AIDS, ARC, and asymptomatic homosexuals. J. Clin. Immunol. 1986. 6: 502-505.
33. + T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J. Immunol. 1995. 155: 5046-5056.
34. Hazzan, M., Labalette, M., Noel, C., Lelievre, G. and Dessaint, J. P., Recall response to cytomegalovirus in allograft recipients. Transplantation 1997. 63: 693-698.
35. + cells: new clues to their origin, specificity, and function. J. Exp. Med. 1995. 182: 633-638.
36. Poggi, A., Costa, P., Tomasello, E. and Moretta, L., IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. Eur. J. Immunol. 1998. 28: 1611-1616.
37. Prussin, C. and Foster, B., TCR Vα24 and Vβ11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J. Immunol. 1997. 159: 5862-5870.
38. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Tanaguchi, M., CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
39. Brossay, L., Chioda, M., Burdin, N., Koezuka, Y., Casorati, G., Dellabona, P. and Kronenberg, M., CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 1998. 188: 1521-1528.
40. + subset. J. Immunol. 1995. 154: 6182-6187.
41. Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L. and Parham, P., Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997. 7: 739-751.
42. Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C. and Moretta, L., Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 1997. 155: 105-117.
43. + immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. Eur. J. Immunol. 1996. 26: 1266-1272.
44. Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., Hurley, A., Markowicz, M., Ho, D. D., Nixon, D. F. and McMichael, A. J., Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998. 279: 2103-2106.
45. Valmori, D., Fonteneau, J. F., Marañón Lizana, C., Gervois, N., Liénard, D., Rimoldi, D., Jongeneel, C. V., Jotereau, F., Cerottini, J.-C. and Romero, P., Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogs. J. Immunol. 1998. 160: 1750-1758.